Doron Levin

CSO at Epeius Pharma
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Israel, IL
Languages
  • English Full professional proficiency
  • Hebrew Native or bilingual proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Israel
    • Biotechnology
    • 1 - 100 Employee
    • CSO
      • Oct 2022 - Present

      Epeius Pharma, a cell therapy company, is developing next generation biological vehicle for delivery of therapeutic proteins into the central nervous system (CNS). Responsibilities:  Leading the development of drug discovery, based on academia licensed IP.  Manage execution of research plan and budget, with the emphasis on preclinical studies, including extensive adaptations of the workplan to the investment round.  Leading a group of scientists from the life sciences and… Show more Epeius Pharma, a cell therapy company, is developing next generation biological vehicle for delivery of therapeutic proteins into the central nervous system (CNS). Responsibilities:  Leading the development of drug discovery, based on academia licensed IP.  Manage execution of research plan and budget, with the emphasis on preclinical studies, including extensive adaptations of the workplan to the investment round.  Leading a group of scientists from the life sciences and chemical engineering fields.  Manage a variety of biology CROs and consultants.  Leading investment processes with venture capital funds and pharma companies.  Preparing Israel Innovation Authority (IIA) submissions and discussions including scientific and operational aspects.  Presenting project progress and risk assessment/mitigation plans to the company Board, SAB and FutuRx management on a regular basis, including budgetary considerations and challenges. Show less Epeius Pharma, a cell therapy company, is developing next generation biological vehicle for delivery of therapeutic proteins into the central nervous system (CNS). Responsibilities:  Leading the development of drug discovery, based on academia licensed IP.  Manage execution of research plan and budget, with the emphasis on preclinical studies, including extensive adaptations of the workplan to the investment round.  Leading a group of scientists from the life sciences and… Show more Epeius Pharma, a cell therapy company, is developing next generation biological vehicle for delivery of therapeutic proteins into the central nervous system (CNS). Responsibilities:  Leading the development of drug discovery, based on academia licensed IP.  Manage execution of research plan and budget, with the emphasis on preclinical studies, including extensive adaptations of the workplan to the investment round.  Leading a group of scientists from the life sciences and chemical engineering fields.  Manage a variety of biology CROs and consultants.  Leading investment processes with venture capital funds and pharma companies.  Preparing Israel Innovation Authority (IIA) submissions and discussions including scientific and operational aspects.  Presenting project progress and risk assessment/mitigation plans to the company Board, SAB and FutuRx management on a regular basis, including budgetary considerations and challenges. Show less

    • Israel
    • Biotechnology Research
    • CSO
      • Mar 2020 - Sep 2022

      JAMM Therapeutics is a drug discovery company developing small molecule modulators for the treatment of systemic lupus erythematosus (SLE) and other related autoimmune diseases. Responsibilities:  Leading the development of drug discovery, based on academia licensed IP.  Manage execution of research plan and budget, including preclinical discovery and development activities.  Leading a group of scientists (PhDs) from the life sciences and medicinal chemistry fields… Show more JAMM Therapeutics is a drug discovery company developing small molecule modulators for the treatment of systemic lupus erythematosus (SLE) and other related autoimmune diseases. Responsibilities:  Leading the development of drug discovery, based on academia licensed IP.  Manage execution of research plan and budget, including preclinical discovery and development activities.  Leading a group of scientists (PhDs) from the life sciences and medicinal chemistry fields.  Manage a variety of chemistry and biology CROs and consultants.  Achieve fundable milestones and effectively execute go/no-go decisions.  Preparing Israel Innovation Authority (IIA) submissions and discussions including scientific and operational aspects.  Presenting project progress and risk assessment/mitigation plans to the company Board, SAB and FutuRx management on a regular basis, including budgetary considerations and challenges.  Leading investment processes with venture capital funds and pharma companies. Show less JAMM Therapeutics is a drug discovery company developing small molecule modulators for the treatment of systemic lupus erythematosus (SLE) and other related autoimmune diseases. Responsibilities:  Leading the development of drug discovery, based on academia licensed IP.  Manage execution of research plan and budget, including preclinical discovery and development activities.  Leading a group of scientists (PhDs) from the life sciences and medicinal chemistry fields… Show more JAMM Therapeutics is a drug discovery company developing small molecule modulators for the treatment of systemic lupus erythematosus (SLE) and other related autoimmune diseases. Responsibilities:  Leading the development of drug discovery, based on academia licensed IP.  Manage execution of research plan and budget, including preclinical discovery and development activities.  Leading a group of scientists (PhDs) from the life sciences and medicinal chemistry fields.  Manage a variety of chemistry and biology CROs and consultants.  Achieve fundable milestones and effectively execute go/no-go decisions.  Preparing Israel Innovation Authority (IIA) submissions and discussions including scientific and operational aspects.  Presenting project progress and risk assessment/mitigation plans to the company Board, SAB and FutuRx management on a regular basis, including budgetary considerations and challenges.  Leading investment processes with venture capital funds and pharma companies. Show less

    • Israel
    • Biotechnology
    • 1 - 100 Employee
    • Consultant
      • Jul 2019 - Feb 2020

       Preparing of grant applications for the Israel Innovation Authority (IIA) including writing the scientific background, designing work plan, defining milestones, planning budget and manpower and presenting the project to the IIA examiners.  For a FutuRx portfolio company, TNIK Therapeutics: Supporting the development of a new experimental system including reviewing relevant experimental protocols, identifying and evaluating antibodies and other components required for assay establishment,… Show more  Preparing of grant applications for the Israel Innovation Authority (IIA) including writing the scientific background, designing work plan, defining milestones, planning budget and manpower and presenting the project to the IIA examiners.  For a FutuRx portfolio company, TNIK Therapeutics: Supporting the development of a new experimental system including reviewing relevant experimental protocols, identifying and evaluating antibodies and other components required for assay establishment, supporting data analysis and troubleshooting efforts. Show less  Preparing of grant applications for the Israel Innovation Authority (IIA) including writing the scientific background, designing work plan, defining milestones, planning budget and manpower and presenting the project to the IIA examiners.  For a FutuRx portfolio company, TNIK Therapeutics: Supporting the development of a new experimental system including reviewing relevant experimental protocols, identifying and evaluating antibodies and other components required for assay establishment,… Show more  Preparing of grant applications for the Israel Innovation Authority (IIA) including writing the scientific background, designing work plan, defining milestones, planning budget and manpower and presenting the project to the IIA examiners.  For a FutuRx portfolio company, TNIK Therapeutics: Supporting the development of a new experimental system including reviewing relevant experimental protocols, identifying and evaluating antibodies and other components required for assay establishment, supporting data analysis and troubleshooting efforts. Show less

    • Israel
    • Biotechnology Research
    • 1 - 100 Employee
    • Scientist
      • Aug 2014 - 2019

       Develop project plans, timelines and deliverables, including support of IP filing for novel drug targets in immuno-oncology.  Manage external vendors and CROs.  An expert in protein-protein interaction, protein-cell binding and antibody blocking assays.  Leading areas of identification and validation of putative counterparts for novel immune checkpoints.  Computational analysis of gene expression and functional enrichment analysis.  Develop project plans, timelines and deliverables, including support of IP filing for novel drug targets in immuno-oncology.  Manage external vendors and CROs.  An expert in protein-protein interaction, protein-cell binding and antibody blocking assays.  Leading areas of identification and validation of putative counterparts for novel immune checkpoints.  Computational analysis of gene expression and functional enrichment analysis.

    • Israel
    • Research
    • 700 & Above Employee
    • Postdoctoral Fellow
      • Jan 2014 - Jul 2014

      Exploring interferon-induced signal transduction: gene and protein expression and phosphoproteome dynamic changes (while mentoring a PhD student).

    • PhD student
      • Mar 2009 - Jan 2014

      Thesis: Studying the biophysical and molecular mechanisms regulating the differential activity of type I interferons. Highly experienced in cell biology, gene and protein expression analysis (including high-throughput screening methodolgies) and cell signaling, protein-protein interaction techniques, molecular biology, biochemistry and biophysical characterization of proteins. Collaborating with research groups in Israel and abroad.

    • Tutor in life sciences
      • 2009 - 2014

    • MSc student
      • Oct 2006 - Dec 2008

      Thesis: MicroRNAs in the Hox cluster. Thesis: MicroRNAs in the Hox cluster.

    • Researcher
      • 2004 - 2006

    • Israel
    • Higher Education
    • 700 & Above Employee
    • BSc student
      • 2003 - 2006

    • Israel
    • Armed Forces
    • 700 & Above Employee
    • Officer (head of section)
      • Mar 1998 - Jun 2003

Education

  • Weizmann Institute of Science
    Doctor of Philosophy (Ph.D.), Biology
    2009 - 2014
  • Weizmann Institute of Science
    Master's Degree, Biology
    2006 - 2008
  • Tel Aviv University
    Bachelor of Science (BSc), Biology
    2003 - 2006

Community

You need to have a working account to view this content. Click here to join now